(Total Views: 449)
Posted On: 01/17/2020 11:59:49 AM
Post# of 153864
Re: craigakess #15306
I agree.
The common theme and longtime hindrance is cash (keeps CYDY on OTC, limits trial progress, PR reach, etc.). I'm sure they could do a better job turning over rocks and creating buzz, but efforts like that are likely come at a premium. I wouldn't think any PR firm will has an "only turning rocks and creating buzz" package......it is likely structured as a base + option 1, option 2, etc. with an associated dollar amount. We will get there, but IMO right now until cash allows I believe they will continue to advance the science that will create the "world series" buzz on its own as you said. FWIW, I agree with this course of action......funding priorities after science to me are paying liabilities, paying off convertible notes and then PR option packages.
The common theme and longtime hindrance is cash (keeps CYDY on OTC, limits trial progress, PR reach, etc.). I'm sure they could do a better job turning over rocks and creating buzz, but efforts like that are likely come at a premium. I wouldn't think any PR firm will has an "only turning rocks and creating buzz" package......it is likely structured as a base + option 1, option 2, etc. with an associated dollar amount. We will get there, but IMO right now until cash allows I believe they will continue to advance the science that will create the "world series" buzz on its own as you said. FWIW, I agree with this course of action......funding priorities after science to me are paying liabilities, paying off convertible notes and then PR option packages.
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
